Versant Capital Management »

Lenz Therapeutics shares owned by Versant Capital Management

Quarter-by-quarter ownership of Lenz Therapeutics (LENZ) shares owned by Versant Capital Management from 13F filings

Historical chart of Versant Capital Management investment in Lenz Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lenz Therapeutics held by Versant Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lenz Therapeutics by Versant Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $558 12 46.58
2025-06-30 $351 12 29.33

More positions owned by Versant Capital Management

Avantis International Equity Etf Etf (AVDE)
Avantis Emerging Markets Equity Etf Etf (AVEM)
Dimensional U.s. Core Equity 2 Etf Etf (DFAC)
Microsoft Stock (MSFT)
Flexshares Tr Mornstar Upstr Etf (GUNR)
Vaneck Gold Miners Etf Etf (GDX)
Dimensional International Core Equity 2 Etf Etf (DFIC)
Ishares S&p Global Energy Etf (IXC)
Global X Fds Global X Ftse Greece 20 Etf Etf (GREK)
Nvidia Corp Stock (NVDA)
Apple Stock (AAPL)
Vanguard Total Stk Mkt Etf (VTI)
Spdr S&p Global Natural Resources Etf Etf (GNR)
Dimensional Us Marketwide Value Etf Etf (DFUV)
Ishares Gold Trust Micro Etf Of Benef Interest Etf (IAUM)

View all positions for Versant Capital Management

Top funds holding Lenz Therapeutics

RA Capital Management
Falcon Edge Capital
Versant Venture Management
BlackRock
Vanguard Group
UBS Group
Paradigm Biocapital Advisors
72 Investment Holdings
Tang Capital Management
Rtw Investments
First Light Asset Management
Adage Capital Partners GP
Franklin Resources
Morgan Stanley
Geode Capital Management

View all funds holding Lenz Therapeutics